Increased medial thalamic creatine-phosphocreatine found by proton magnetic resonance spectroscopy in children with obsessive-compulsive disorder versus major depression and healthy controls.
Altered brain creatine-phosphocreatine levels might reflect changes in brain energy use and have been implicated in the pathogenesis of obsessive-compulsive disorder and major depressive disorder. We used proton magnetic resonance spectroscopy to measure absolute concentrations of creatine-phosphocreatine in the right and left medial thalami in 18 pediatric patients with major depressive disorder 9 to 17 years of age, 18 case-matched healthy controls, and 27 patients with obsessive-compulsive disorder 7 to 16 years old. The two patient groups were psychotropic drug naive and were not comorbid for the diagnosis of the comparison group. We found significantly increased left and right medial thalamic creatine-phosphocreatine concentrations in patients with obsessive-compulsive disorder compared with both healthy controls and patients with major depression. Creatine-phosphocreatine concentrations did not differ significantly between patients with major depression and healthy controls. Our data suggest that increased medial thalamic creatine-phosphocreatine concentrations in patients with untreated obsessive-compulsive disorder reflect altered energy use in the medial thalamus and might differentiate patients with obsessive-compulsive disorder from healthy controls and patients with major depression. Although these results must be considered preliminary, further study of the diagnostic specificity of creatine-phosphocreatine in obsessive-compulsive disorder is indicated.
Mirza
Yousha
Y
Department of Psychiatry and Behavioral Neurosciences, Wayne State University School of Medicine, Detroit, MI 48201, USA.
O'Neill
Joseph
J
Smith
Ethan A
EA
Russell
Aileen
A
Smith
Janet M
JM
Banerjee
S Preeya
SP
Bhandari
Rashmi
R
Boyd
Courtney
C
Rose
Michelle
M
Ivey
Jennifer
J
Renshaw
Perry F
PF
Rosenberg
David R
DR
D000293:Adolescent; D001931:Brain Mapping; D002648:Child; D003401:Creatine / Q000378:metabolism*; D003865:Major Depressive Disorder / Q000175:diagnosis* / Q000503:physiopathology; D004292:Dominance, Cerebral / Q000502:physiology; D004734:Energy Metabolism / Q000502:physiology; D005260:Female; D006801:Humans; D007091:Image Processing, Computer-Assisted; D008279:Magnetic Resonance Imaging; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D009771:Obsessive-Compulsive Disorder / Q000175:diagnosis* / Q000503:physiopathology; D010725:Phosphocreatine / Q000378:metabolism*; D011237:Predictive Value of Tests; D012016:Reference Values; D013788:Thalamus / Q000473:pathology / Q000503:physiopathology*
D010725:Phosphocreatine; D003401:Creatine